Advancements in Epigenetic Reprogramming

This chapter highlights the recent breakthroughs at Life Biosciences, particularly focusing on their clinical trials in partial epigenetic reprogramming for optic neuropathies. It also discusses their accolades, including recognition as a top biotech in Boston and participation in significant medical conferences, showcasing their innovative contributions to the field.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app